Connection

Charles Smith to Antimetabolites, Antineoplastic

Back to Details
This is a "connection" page, showing publications Charles Smith has written about Antimetabolites, Antineoplastic.
Charles Smith
Connection Strength
0.135
Antimetabolites, Antineoplastic
  1. Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640. Oncotarget. 2016 Sep 13; 7(37):60181-60192.
    View in: PubMed
    Score: 0.135
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.